Entera Bio Ltd (ENTX): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Entera Bio Ltd (ENTX) following the 2026 Q1 hedge fund 13F filings?

As of today, ENTX has moved +17.5% since the 2026 Q1 13F filing date (May 15, 2026), compared to +695.4% for the XLV sector ETF — an outperformance of -677.9%. Since the quarter end (March 31, 2026), ENTX gained +33.3% vs +708.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Entera Bio Ltd (ENTX)

25 + Investors. Track Smart Money conviction in ENTX. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ENTX

Based on 25 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds added ENTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

25 hedge funds hold ENTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +32% more funds vs a year ago

fund count last 6Q

+6 new funds entered over the past year (+32% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟡

Slight buying edge — 54% buying

13 buying11 selling

Last quarter: 13 funds bought or added vs 11 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

➡️

Steady new buyers — ~8 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 3 → 3 → 4 → 8. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

40% of holders stayed for 2+ years

■ 40% conviction (2yr+) ■ 28% medium ■ 32% new

10 out of 25 hedge funds have held ENTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares -16%, value -52%

Value

-52%

-15%

Last quarter: funds added -16% more shares while total portfolio value only changed -52%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

➡️

Steady discovery — ~8 new funds/quarter

5 → 3 → 3 → 4 → 8 new funds/Q

New funds entering each quarter: 3 → 3 → 4 → 8. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🏛️

Veteran-anchored — 52% veterans vs 32% newcomers

■ 52% veterans ■ 16% 1-2yr ■ 32% new

Entry-cohort mix of 25 holders: 13 (52%) are 2+ year veterans, 4 entered 1–2 years ago, and 8 (32%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

📋

Smaller funds dominant — 6% AUM from top-100

6% from top-100 AUM funds

8 of 25 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.1

out of 10

Moderate Exit Risk

Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	25	21	19.05%
13F Shares	8M	9M	-15.65%
Total Value	$9M	$18M	-52.06%
New Positions	8	4	+4
Increased Positions	5	6	-1
Closed Positions	4	4	-
Reduced Positions	7	4	+3
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

19.05%

13F Shares

-15.65%

Total Value

$9M

$18M

-52.06%

New Positions

Increased Positions

-1

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q1)

25 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ENTX. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 23 ENTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Knoll Capital Management, LLC	3.59%	5,881,879	$6.5M
2	Seven Fleet Capital Management LP	0.07%	205,542	$228K
3	Parkman Healthcare Partners LLC	0.03%	288,670	$320K
4	Gem Investment Advisors, LLC	0.02%	19,135	$21K
5	Diadema Partners LP	0.00%	23,260	$26K
6	XTX Topco Ltd	0.00%	131,622	$146K
7	Persistent Asset Partners Ltd	0.00%	5,881	$7K
8	Signature Estate & Investment Advisors LLC	0.00%	47,328	$53K
9	Renaissance Technologies LLC	0.00%	473,442	$526K
10	Schonfeld Strategic Advisors LLC	0.00%	55,223	$61K
11	Marshall Wace, LLP	0.00%	195,780	$217K
12	Citadel Advisors LLC	0.00%	245,577	$273K
13	HighTower Advisors, LLC	0.00%	36,830	$41K
14	Hrt Financial LP	0.00%	15,492	$17K
15	Point72 Asset Management, L.P.	0.00%	12,382	$14K
16	PNC Financial Services Group, INC.	0.00%	10,000	$11K
17	Jane Street Group, LLC	0.00%	32,915	$37K
18	Caitong International Asset Management Co., Ltd	0.00%	20	—
19	Bank of America Corp /de/	0.00%	12,000	$13K
20	UBS Group AG	0.00%	3,212	$4K
21	Group One Trading LLC	0.00%	51	—
22	SBI Securities Co., Ltd.	0.00%	2	—
23	Morgan Stanley	0.00%	400	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Entera Bio Ltd (ENTX)

What does the Smart Money Trend signal show for ENTX?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ENTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ENTX?

Slight buying edge — 54% buying: Last quarter: 13 funds bought or added vs 11 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ENTX holders?

Smaller funds dominant — 6% AUM from top-100: 8 of 25 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ENTX?

40% of holders stayed for 2+ years: 10 out of 25 hedge funds have held ENTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Entera Bio Ltd (ENTX) following the 2026 Q1 hedge fund 13F filings?

As of today, ENTX has moved +17.5% since the 2026 Q1 13F filing date (May 15, 2026), compared to +695.4% for the XLV sector ETF — an outperformance of -677.9%. Since the quarter end (March 31, 2026), ENTX has gained +33.3% vs +708.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Entera Bio Ltd (ENTX)

Smart Money Signals — ENTX

Buying streak — 1 quarter in a row

At the ownership peak (100% of max)

Fast accumulation — +32% more funds vs a year ago

Slight buying edge — 54% buying

Steady new buyers — ~8 new funds per quarter

40% of holders stayed for 2+ years

Buying through price weakness — shares -16%, value -52%

Steady discovery — ~8 new funds/quarter

Veteran-anchored — 52% veterans vs 32% newcomers

Smaller funds dominant — 6% AUM from top-100

Institutional Sentiment Summary — ENTX

Hedge Fund Ownership: ENTX

Market Analysis: ENTX

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ENTX

Is It Too Late to Buy Entera Bio Ltd (ENTX) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: ENTX

Statistics: ENTX

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Entera Bio Ltd (ENTX)

Welcome to 13Foresight!